# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-021629
Filing Date
2021-11-04
Accepted
2021-11-04 09:11:09
Documents
70
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sgmo-20210930.htm iXBRL | 10-Q | 1670245
2 | EX-10.1 | sgmo-20210930xex101_employ.htm | EX-10.1 | 37393
3 | EX-31.1 | sgmo-20210931xex311.htm | EX-31.1 | 10159
4 | EX-31.2 | sgmo-20210930xex312.htm | EX-31.2 | 10274
5 | EX-32.1 | sgmo-20210930xex321.htm | EX-32.1 | 7232
11 | GRAPHIC | sgmo-20210930_g1.jpg | GRAPHIC | 47881
12 | GRAPHIC | sgmo-20210930_g2.jpg | GRAPHIC | 136221
| Complete submission text file | 0001628280-21-021629.txt |  | 8135369

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sgmo-20210930.xsd | EX-101.SCH | 57660
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | sgmo-20210930_cal.xml | EX-101.CAL | 74071
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | sgmo-20210930_def.xml | EX-101.DEF | 292360
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sgmo-20210930_lab.xml | EX-101.LAB | 571797
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sgmo-20210930_pre.xml | EX-101.PRE | 411226
13 | EXTRACTED XBRL INSTANCE DOCUMENT | sgmo-20210930_htm.xml | XML | 1367783

Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 211378459
SIC: 2836 Biological Products, (No Diagnostic Substances)